Multimedia AI for Precision Oncology

Register now.

Continuing Medical Education (CME) credits now available – This activity has been approved for AMA PRA Category 1 Credits™.

In this session, Dr. Anant Madabhushi will highlight the development of radiopathomics, an AI-driven framework that integrates radiology and digital pathology to capture tumor heterogeneity across spatial scales for improved diagnosis, prognosis, and therapeutic response prediction. He will present validation studies across multiple cancers demonstrating how these multimodal biomarkers can inform treatment selection, anticipate resistance, and enable more precise, personalized oncology care.

Anant Madabhushi, Ph.D., is the Robert W. Woodruff Professor of Biomedical Engineering and serves on the faculty in the Departments of Pathology, Biomedical Informatics, Urology, Radiation Oncology, Radiology and Imaging Sciences, Global Health and Computer and Information Sciences at Emory University. He is also a Research Career Scientist at the Atlanta Veterans Administration Medical Center and serves as the inaugural executive director of the newly formed Emory Empathetic AI for Health Institute. Dr. Madabhushi has authored over 500 peer-reviewed publications and holds more than 225 either issued or pending patents in the areas of artificial intelligence, radiomics, medical image analysis, computer-aided diagnosis, and computer vision.

Dr. Madabhushi is a Fellow of the American Institute of Medical and Biological Engineering (AIMBE), the Institute for Electrical and Electronic Engineers (IEEE), the American Association for the Advancement of Science (AAAS), and the National Academy of Inventors (NAI). His work on "Smart Imaging Computers for Identifying Lung Cancer Patients Who Need Chemotherapy" was recognized by Prevention Magazine as one of the top 10 medical breakthroughs of 2018. In 2019, Nature Magazine hailed him as one of 5 scientists developing "offbeat and innovative approaches for cancer research." From 2019 to 2022, Dr. Madabhushi was named to The Pathologist’s Power List of 100 inspirational and influential professionals in pathology. He is also an entrepreneur, having founded three companies: Elucid Bioimaging, Ibris Inc., and Picture Health. In 2019, Elucid Bioimaging obtained FDA approval for one of its technologies for the use of AI in carotid plaque characterization.